Maravai LifeSciences (MRVI) Earnings
|
Expand Research on MRVI
| Next EPS Date | 8/11/26 | EPS Growth Rate | +37.5% |
|---|---|---|---|
| Average EPS % Beat Rate | +37.1% | Revenue Growth Rate | +12.1% |
| Average % Move 1-Wk after EPS | +16.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/26  |
Q226 | N/A | -$0.05 | N/A | N/A | $53.12M | = | N/A | N/A | ||
| 5/7/26 | Q126 | $0.01 | -$0.05 | +$0.06 | $65.8M | $52.9M | = |  | | Details | |
| 2/25/26 | Q425 | -$0.04 | -$0.07 | +$0.03 | $49.9M | $49.02M | = | | | Details | |
| 11/6/25 | Q325 | -$0.08 | -$0.08 | $0.00 | $41.6M | $49.04M | = | | | Details | |
| 8/11/25 | Q225 | -$0.08 | -$0.07 | -$0.01 | $47.4M | $47.61M | = | | | Details | |
| 5/12/25 | Q125 | -$0.08 | -$0.07 | -$0.01 | $46.9M | $45.6M | = | | | Details | |
| 3/18/25 | Q424 | -$0.06 | -$0.04 | -$0.02 | $56.6M | $56.67M | = | | | Details | |
| 2/27/25 |
Q424 | N/A | -$0.04 | N/A | N/A | $56.67M | = | N/A | N/A |
